Aptorum Group Common Stock Net 2018-2024 | APM

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Aptorum Group common stock net from 2018 to 2024. Common stock net can be defined as the value of common equity ownership.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Aptorum Group common stock net from 2018 to 2024. Common stock net can be defined as the value of common equity ownership.

Related Stocks
Company Name	Market Cap
Chugai Pharmaceutical (CHGCY)	$70B
Zoetis (ZTS)	$68.3B
Takeda Pharmaceutical (TAK)	$47.7B
Daiichi Sankyo, - (DSNKY)	$47.6B
BeOne Medicines - (ONC)	$35.2B
Sandoz Group AG (SDZNY)	$26.1B
Summit Therapeutics (SMMT)	$19.8B
Merck (MKKGY)	$17.1B
Shionogi (SGIOY)	$15.2B
United Therapeutics (UTHR)	$14.1B
Neurocrine Biosciences (NBIX)	$13.2B
Orion OYJ (ORINY)	$10.8B
IPSEN (IPSEY)	$10.6B
Eisai (ESAIY)	$9.2B
Madrigal Pharmaceuticals (MDGL)	$8.2B
Corcept Therapeutics (CORT)	$7.6B
Grifols, S.A (GRFS)	$7.4B
Ionis Pharmaceuticals (IONS)	$7B
Stevanato Group S.p.A (STVN)	$6.9B
Hikma Pharmaceuticals Plc (HKMPF)	$5.3B
Ono Pharmaceutical (OPHLF)	$5.1B
Soleno Therapeutics (SLNO)	$3.8B
AMNEAL PHARMACEUTICALS, INC (AMRX)	$3B
Crinetics Pharmaceuticals (CRNX)	$2.9B
NewAmsterdam Pharma (NAMS)	$2.8B
Hypermarcas (HYPMY)	$2.7B
Catalyst Pharmaceuticals (CPRX)	$2.5B
Centessa Pharmaceuticals (CNTA)	$2.4B
Ocular Therapeutix (OCUL)	$2.2B
Endo (NDOI)	$1.8B